Luteoma of pregnancy

Summary

Luteoma of pregnancy (MONDO:0004387) is a disease. A subtype of ovarian disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	luteoma of pregnancy
Mondo ID	MONDO:0004387
MeSH	D018311
DOID	DOID:7880
NCIT	C40445
UMLS	C0334209
MedGen	137726
Is cancer (heuristic)	no

Also known as: leuteoma of pregnancy

Disease family

This is a subtype of ovarian disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › reproductive system disorder › gonadal disorder › ovarian disorder › luteoma of pregnancy

Related subtypes (10): ovarian dysfunction, anovulation, ovarian cyst, ovarian stromal hyperthecosis, ovarian endometriosis, oophoritis, ovarian hyperstimulation syndrome, ovarian neoplasm, ovarian remnant syndrome, ovarian ectopic pregnancy

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.